Hydrochloric Acid

Hydrochloric Acid

SCHEMBL237984

CCN(CC)c1ccc(C(c2ccc(N(CC)CC)cc2C)c2ccc(N(CC)CC)cc2C)c(C)c1.Cl.Cl.Cl

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA known ✓ P10253 2/20 0.50
GLA known ✓ P06280 2/20 0.41
S1PR1 known ✓ P21453 3/20 0.40
S100B P04271 1/20 0.56
MAPT P10636 5/20 0.50
HTT P42858 4/20 0.50
PKM P14618 1/20 0.50
MCL1 Q07820 1/20 0.50
TERT O14746 1/20 0.44
ALDH1A1 P00352 8/20 0.41
L3MBTL1 Q9Y468 4/20 0.41
CYP3A4 P08684 3/20 0.41
MAPK1 P28482 3/20 0.41
HSD17B10 Q99714 3/20 0.41
HPGD P15428 2/20 0.41
CASP1 P29466 2/20 0.41
CASP7 P55210 2/20 0.41
IGLV6-57 P01721 1/20 0.41
ATM Q13315 1/20 0.41
HIF1A Q16665 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL81551 0.98 S100B (0.58) S100BMAPTHTTGAAPKM
Hydrochloric Acid SCHEMBL6373886 0.94 S100B (0.55) S100BMAPTHTTGAAPKM
SCHEMBL6253717 0.91 S100B (0.51) S100BMAPTHTTGAAPKM
SCHEMBL10952039 0.89 S100B (0.53) S100BMAPTHTTGAAPKM
Oxalic Acid SCHEMBL238205 0.88 S100B (0.49) S100BMAPTHTTGAAPKM
SCHEMBL13804083 0.87 S100B (0.51) S100BMAPTHTTGAAPKM
SCHEMBL656825 0.87 S100B (0.51) S100BMAPTHTTGAAPKM
SCHEMBL658351 0.87 S100B (0.51) S100BMAPTHTTGAAPKM
SCHEMBL6271329 0.86 S100B (0.58) S100BMAPTHTTGAAPKM
SCHEMBL8074081 0.85 S100B (0.56) S100BMAPTHTTGAAPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2541322-B1 Composition, process of preparation and method of application and exposure for light imaging paper INT PAPER CO (US) 2015-08-12 EP disclosed
EP-2899592-A1 Coated substrate comprising a dual wavelength image-forming particulate composition and a process for making said composition INTERNATIONAL PAPER COMPANY (US) 2015-07-29 EP disclosed
US-20150185608-A1 IMAGING PARTICULATES, PAPER AND PROCESS, AND IMAGING OF PAPER USING DUAL WAVELENGTH LIGHT INTERNATIONAL PAPER COMPANY 2015-07-02 US disclosed
US-8980523-B2 Imaging particulates, paper and process, and imaging of paper using dual wavelength light INTERNATIONAL PAPER COMPANY (US) 2015-03-17 US disclosed
EP-2340463-B1 IMAGING PARTICULATE COMPOSITION AND IMAGING PROCESS USING DUAL WAVELENGTH LIGHT INT PAPER CO (US) 2014-12-17 EP disclosed
US-20140080044-A1 Imaging Particulates, Paper and Process, and Imaging of Paper Using Dual Wavelength Light INTERNATIONAL PAPER COMAPNY (US) 2014-03-20 US disclosed
US-20140080057-A1 Composition, process of preparation and method of application and exposure for light imaging paper INTERNATIONAL PAPER COMAPNY (US) 2014-03-20 US disclosed
US-8586279-B2 Imaging particulates, paper and process, and imaging of paper using dual wavelength light INTERNATIONAL PAPER COMPANY (US) 2013-11-19 US disclosed
US-8586280-B2 Composition, process of preparation and method of application and exposure for light imaging paper INTERNATIONAL PAPER COMPANY (US) 2013-11-19 US disclosed
EP-2541322-A1 Composition, process of preparation and method of application and exposure for light imaging paper INTERNATIONAL PAPER COMPANY (US) 2013-01-02 EP disclosed
EP-0046271-B1 PHOTOSENSITIVE COMPOSITIONS AND ELEMENTS CONTAINING SUBSTITUTED HYDROXYLAMINE E.I. DU PONT DE NEMOURS AND COMPANY (US) 1983-10-19 EP disclosed
EP-0066870-A2 Photoimaging compositions containing substituted cyclohexadienone compounds E.I. DU PONT DE NEMOURS AND COMPANY (US) 1982-12-15 EP disclosed
US-4341860-A A P-DI-OR TRICHLOROCYCLOHEXADIENONE OXIDIZER AND A LEUCO DYE OR UNSATURATED MONOMER; PHOTORESISTS; PHOTOPRINTOUT ELEMENTS E. I. DU PONT DE NEMOURS AND COMPANY (US) 1982-07-27 US disclosed
US-4339527-A BIS/ACRYLOYLOXYALKYL/HYDROCARBYLDICARBOXYLATES E. I. DU PONT DE NEMOURS AND COMPANY (US) 1982-07-13 US disclosed
EP-0046271-A1 Photosensitive compositions and elements containing substituted hydroxylamine E.I. DU PONT DE NEMOURS AND COMPANY (US) 1982-02-24 EP disclosed
US-4311783-A Dimers derived from unsymmetrical 2,4,5,-triphenylimidazole compounds as photoinitiators E. I. DU PONT DE NEMOURS AND COMPANY (US) 1982-01-19 US disclosed
US-4298678-A PHOTOOXIDANT AND LEUCO DYE E. I. DU PONT DE NEMOURS AND COMPANY (US) 1981-11-03 US disclosed
EP-0024629-A2 Photoimaging composition comprising a 2,4,5-triphenylimidazolyl dimer and at least one compound selected from the group consisting of a leuco dye and a polymerizable ethylenically unsaturated monomer E.I. DU PONT DE NEMOURS AND COMPANY (US) 1981-03-11 EP disclosed
US-4252887-A HIGH SPEED IMAGING; PHOTOSENSITIVE TO LONGER WAVELENGTHS; USED WITH PHOTOPOLYMERIZABLE OLEFIN; OVERLAY FILMS E. I. DU PONT DE NEMOURS AND COMPANY (US) 1981-02-24 US disclosed
US-4230790-A COMPRISING A PHOTOINITIATOR, A POLYMERIC BINDER, AND AN ACRYLIC ESTER OF A DICARBOXYLIC ACID AND A GLYCOL ACRYLATE E. I. DU PONT DE NEMOURS AND COMPANY (US) 1980-10-28 US disclosed